DR. REDDY'S LABORATORIES LIMITED

🇱🇰Sri Lanka
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Letrozole
First Posted Date
2011-06-17
Last Posted Date
2011-06-27
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
36
Registration Number
NCT01375452

Bioavailability Study of Letrozole Tablets 2.5 mg of Dr.Reddy's Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Letrozole
First Posted Date
2011-06-14
Last Posted Date
2011-06-14
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
36
Registration Number
NCT01372982

Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Desloratadine and pseudoephedrine
First Posted Date
2011-06-14
Last Posted Date
2011-06-14
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
34
Registration Number
NCT01373138
Locations
🇨🇦

SFBC Anapharm, Sainte-Foy (Quebec), Canada

Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition

Phase 1
Completed
Conditions
Fasting
Interventions
Drug: Reminyl
First Posted Date
2011-06-13
Last Posted Date
2011-06-30
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
28
Registration Number
NCT01372280

Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition

Phase 1
Completed
Conditions
Fed
Interventions
Drug: Reminyl
First Posted Date
2011-06-13
Last Posted Date
2011-06-30
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
24
Registration Number
NCT01372306

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions

Phase 1
Completed
Conditions
Fed
Interventions
Drug: CIPRO®XR
First Posted Date
2011-06-13
Last Posted Date
2011-06-13
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
32
Registration Number
NCT01372358
Locations
🇺🇸

NOVUM Pharmaceutical Research Services, Houston, Texas, United States

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions

Phase 1
Completed
Conditions
Fasting
Interventions
Drug: CIPRO®XR
First Posted Date
2011-06-13
Last Posted Date
2011-06-13
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
43
Registration Number
NCT01372345
Locations
🇺🇸

NOVUM Pharmaceutical Research Services, Houston, Texas, United States

An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation

First Posted Date
2011-04-18
Last Posted Date
2020-04-29
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
142
Registration Number
NCT01336647
Locations
🇺🇸

Axis Clinical Trials, Los Angeles, California, United States

🇺🇸

Universal BioPharma Research Institute, Inc., Dinuba, California, United States

Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions

Phase 1
Completed
Conditions
Fed
Interventions
Drug: Desloratadine
First Posted Date
2011-03-14
Last Posted Date
2011-06-08
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
28
Registration Number
NCT01314352
Locations
🇺🇸

SFBC, Ft. Myers, Inc.,, Ft. Myers, Florida, United States

Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions.

Phase 1
Completed
Conditions
Fasting
Interventions
Drug: Desloratadine
First Posted Date
2011-03-14
Last Posted Date
2012-02-20
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
28
Registration Number
NCT01314339
Locations
🇺🇸

SFBC, Ft. Myers, Inc.,, Ft. Myers, Florida, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy